Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Hear Philip N. Newsome, PhD, FRCPE, discuss available approaches to managing NASH, including lifestyle, vitamin E, and compounds that target insulin resistance, including:
Download the slides from this podcast at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics/management-approaches-with-currently-available-treatments/slideset
See more NASH topics at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics
Professor of Hepatology
University of Birmingham
Birmingham, United Kingdom
This program has been made available online.
Hear Brent A. Neuschwander-Tetri, MD, explore NASH screening and the interplay among NAFLD, metabolic syndrome, CV risk, and diabetes risk from CCO
Hear Philip Newsome, PhD FRCPE, discuss the agents in late-phase clinical trials and their potential use in treatment of NASH and fibrosis from CCO
Expert commentary on prevention and emerging treatment strategies for the COVID-19 pandemic from CCO
Interactive on-demand Webcast from CCO featuring expert discussion on managing patients at risk for recurrent hepatic encephalopathy